Trial · NCT07530705
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Adverse events (safety) | From the first dose through 30 days after the last dose for non-serious adverse events, and through 3 months after the last dose for severe adverse events. | Adverse events, including serious adverse events. Assessment methods: spontaneous reports; scheduled laboratory tests (hematology, chemistry, C-reactive protein, urinalysis); vital signs (blood pressure, heart rate, respiratory rate, temparature), physical examinations, and electrocardiogram (QTc interval, arrhythmia). |
| Secondary | PTH(1-84) (efficacy) | Single dose: Predose (within one hour before administration), and 4, 8, 12, 18, 24, 30, 36, 48, 60, and 72 hours postdose. Multiple dose: Predose on Day 1 to 5 (before each dose); and 4, 8, 12, 24, 30, 36, 48, 60, and 72 hours after the last dose. | serum PTH(1-84) |
| Secondary | PTH (efficacy) | Single dose: Predose (within one hour before administration), and 4, 8, 12, 18, 24, 30, 36, 48, 60, and 72 hours postdose. Multiple dose: Predose on Day 1 to 5 (before each dose); and 4, 8, 12, 24, 30, 36, 48, 60, and 72 hours after the last dose | serum PTH |
| Secondary | Serum calcium (efficacy) | Single dose: Predose (within one hour before administration), and 4, 8, 12, 24, 36, 48, and 72 hours postdose. Multiple dose: Predose on Day 1 to 5 (before each dose); and 24, 48, and 72 hours after the last dose | Serum calcium |
| Secondary | Serum phosphorus (efficacy) | Single dose: Predose (within one hour before administration), and 4, 8, 12, 24, 36, 48, and 72 hours postdose. Multiple dose: Predose on Day 1 to 5 (before each dose); and 24, 48, and 72 hours after the last dose | Serum phosphorus |
| Secondary | Serum magnesium (efficacy) | Single dose: Predose (within one hour before administration), and 4, 8, 12, 24, 36, 48, and 72 hours postdose. Multiple dose: Predose on Day 1 to 5 (before each dose); and 24, 48, and 72 hours after the last dose | Serum magnesium |
| Secondary | 1, 25-Dihydroxyvitamin D3 (efficacy) | Single dose: Predose (within one hour before administration); and 24, 48, and 72 hours postdose. Multiple dose: Predose on Day 1, Day 3, Day 5; and 48 hours and 72 hours after the last dose. | Serum 1, 25-Dihydroxyvitamin D3 |
| Secondary | 24-hour urine calcium (efficacy) | Single dose: Predose (within 3 days before administration), and 24, 48, and 72 hours postdose. Multiple dose: Predose on Day 1 to 5 (before each dose), and 24, 48, and 72 hours after the last dose | 24-hour urine calcium (24hUCa) |
| Secondary | Fractional Excretion of calcium (efficacy) | Single dose: Predose (within one hour before administration), and 12, 24, 36, 48, and 72 hours postdose. Multiple dose: Predose on Day 1 to 5 (before each dose), and 24, 48, and 72 hours after the last dose | Fractional Excretion of calcium (FECa) |
| Other | Procollagen type 1 N-terminal propeptide (Exploratory endpoint) | Multiple dose: Predose on Day 1 to 5 (before each dose); and 24, 48, and 72 hours after the last dose | Serum Procollagen type 1 N-terminal propeptide (P1NP) |
| Other | Beta-isomerized C-terminal telopeptide of type 1 collagen (Exploratory endpoint) | Multiple dose: Predose on Day 1 to 5 (before each dose); and 24, 48, and 72 hours after the last dose | Serum Beta-isomerized C-terminal telopeptide of type 1 collagen (β-CTX) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07530705/registered